Lacklustre day for ISEQ

The Dublin stock exchange never stopped the losses it experienced early on in the day despite Bank of Ireland's sale of some of its UK assets and Elan's plans to relaunch its multiple sclerosis drug Tysabri.

Lacklustre day for ISEQ

The Dublin stock exchange never stopped the losses it experienced early on in the day despite Bank of Ireland's sale of some of its UK assets and Elan's plans to relaunch its multiple sclerosis drug Tysabri.

The ISEQ was down 64.37 points to 6,654.98 by close of business this evening.

Already a subscriber? Sign in

You have reached your article limit.

Subscribe to access all of the Irish Examiner.

Annual €130 €80

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited